Merck
Links shared publicly online about this topic
Mendelsohn to Merck
theheart.org — “After 17 years at Tufts, where he later became the chief scientific officer and executive director of the Molecular Cardiology Research Institute, Mendelsohn will become senior vice president of Merck Research Laboratories.” View full resource at theheart.org
Most Recently Shared on June 30, 2010 at 7:47 pm By:
Michael Mendelsohn leaves Tufts for Merck: After 17 years at Tufts, where he later became the chief scientific off... http://bit.ly/ck4Rz1
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on April 11, 2011 at 12:11 pm By:
Merck & Indian firm Sun Pharma establish JV to sell branded generics in emerging markets: http://bit.ly/gyzpiw $MRK
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on October 28, 2011 at 11:13 am By:
Januvia, Janumet up 40%-plus; Victrelis at $31M, $53M YTD RT @Merck: Announcing 3Q financial results. http://t.co/k1KCYZ8q $MRK #pharma
Merck completes acquisition of Inspire
osnsupersite.com — “WHITEHOUSE STATION, N.J. Merck has completed its acquisition of Inspire Pharmaceuticals for $5 per share in cash, the company announce” View full resource at osnsupersite.com
Most Recently Shared on May 17, 2011 at 5:30 pm By:
Inspire Pharmaceuticals to be Acquired by Merck
eyedocnews.com — “Azasite, Elestat and Restasis among treatments in Inspire portfolio.” View full resource at eyedocnews.com
Most Recently Shared on April 7, 2011 at 5:26 pm By:
Discuss: Merck Acquiring Inspire Pharmaceuticals: Merck announced earlier this week that it will be acquiring In... http://bit.ly/hQ6Uzw
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on May 10, 2010 at 9:33 pm By:
Merck Settles Patent Infringement Case for Zetia® (ezetimibe) http://ow.ly/1JiSY
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on October 8, 2009 at 2:52 pm By:
RT @mhuckman: Yep. There's an app for that. "The Merck Manual" now available on iPhone. $MRK $AAPL http://tinyurl.com/pmmrkman
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on October 8, 2009 at 2:18 pm By:
RT @mhuckman: Yep. There's an app for that. "The Merck Manual" now available on iPhone. $MRK $AAPL http://tinyurl.com/pmmrkman
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on October 21, 2010 at 9:03 pm By:
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on January 9, 2009 at 3:16 pm By:
Merck Gets Complete Response Letter from FDA for Use of GARDASIL® in Women Ages 27-45 http://tinyurl.com/969chr
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on November 16, 2009 at 1:31 pm By:
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on July 30, 2009 at 1:52 pm By:
Statement by Merck & Co., Inc. Regarding FOSAMAX® (alendronate sodium) and Rare Cases of Osteonecrosis of the Jaw - http://bit.ly/19dYjj
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on January 6, 2011 at 2:22 pm By:
Merck says NDA for HCV drug boceprevir is accepted in US and EU w/priority review. $VRTX? telaprevir status?: http://bit.ly/fS34ob $MRK
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on December 2, 2010 at 1:53 pm By:
Merck buys SmartCells, glucose-responsive insulin tech coming out of MIT, for up to $500m: http://bit.ly/i5A9cC
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on September 3, 2009 at 1:40 pm By:
Merck Launches SAFLUTAN® (tafluprost) in International Markets - http://bit.ly/fUbwR
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Lisa Jarvis
biotech/pharma reporter at C&EN. bit 'o science, bit 'o business.
-
FiercePharma
FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com
Advertisement

